Malignant Urinary System Neoplasm — Research

Malignant Urinary System Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	56	`("Malignant Urinary System Neoplasm"[tiab] OR "Urinary System Cancer"[tiab] OR "Cancer of Urinary System"[tiab] OR "Cancer of the Urinary System"[tiab] OR "Malignant Urinary System Tumor"[tiab] OR "Malignant neoplasm of urinary organ, unspecified"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	30	`("Malignant Urinary System Neoplasm"[tiab] OR "Urinary System Cancer"[tiab] OR "Cancer of Urinary System"[tiab] OR "Cancer of the Urinary System"[tiab] OR "Malignant Urinary System Tumor"[tiab] OR "Malignant neoplasm of urinary organ, unspecified"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	3	`("Malignant Urinary System Neoplasm"[tiab] OR "Urinary System Cancer"[tiab] OR "Cancer of Urinary System"[tiab] OR "Cancer of the Urinary System"[tiab] OR "Malignant Urinary System Tumor"[tiab] OR "Malignant neoplasm of urinary organ, unspecified"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (238)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 238 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Editor's corner: Heavy metal exposure and the epigenetic landscape of urothelial bladder cancer.
Marianna Kruithof-deJulio · Gene · Dec 5, 2026 · PMID 42692175 · candidate dictionary pubmed
Cost-effectiveness of perioperative pembrolizumab plus enfortumab vedotin for cisplatin-ineligible or cisplatin-declining patients with muscle-invasive bladder cancer in the United States.
Daniel Hill-McManus, Yizhen Lai, Arielle G Bensimon et al. · J Med Econ · Dec 1, 2026 · PMID 42610318 · candidate dictionary pubmed
[Expression of Concern] RIP kinase‑mediated ROS production triggers XAF1 expression through activation of TAp73 in casticin‑treated bladder cancer cells.
Yoon Hee Chung, Daejin Kim · Oncol Rep · Nov 1, 2026 · PMID 42757458 · candidate dictionary pubmed